US President Donald Trump has announced that tariffs on pharmaceutical products could be expected in the "not too distant future", German Pre ...

Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt ...

MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...

MELBOURNE, Australia and INDIANAPOLIS, April 15, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces preliminary results from the Phase ...

J&J faces several headwinds at the start of the year, including patent expiry, talc litigation, and, now, tariffs.

Explore the latest changes in drug pricing as Trump aims to revamp Medicare negotiations for prescription drugs.

TD Cowen analyst Yaron Werber maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) today and set a price target of $59.00.

Artios Pharma Limited (“Artios”), a clinical-stage biotech company led by pioneers of DNA damage response (“DDR”) drug development, today announced that the company’s abstract featuring clinical trial ...

The stock's fall snapped a two-day winning streak.

Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its previously announced non-brokered private placement offering (the ...

NEW YORK CITY, NY / ACCESS Newswire / April 15, 2025 / If you suffered a loss on your Actinium Pharmaceuticals ... defendants made false statements and/or concealed that: (1) the Company's data from ...